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B. henselae antigens (Houston-1 and 
Marseille) compared with the 4 dif-
ferent  B. henselae antigens used in 
the present study. Most reactivity to 
B. henselae in the present study was 
directed against the Swedish isolate 
K68 (27%); only 0.8% of controls had 
antibodies against that antigen.
An increased prevalence of an-
tibodies against B. henselae after ex-
posure to cats has been reported from 
Spain (10). Because seroconversion 
against B. henselae occurred in 2 pa-
tients who had not been scratched, cat 
bites may contribute to transmission 
of B. henselae.
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Fatal Case of 
Israeli Spotted 
Fever after 
Mediterranean 
Cruise
To the Editor: Israeli spotted 
fever (ISF) is caused by Rickettsia 
conorii subsp. israelensis. This recent-
ly described subspecies is genetically 
close to R. conorii subsp. conorii, the 
agent of Mediterranean spotted fever 
(MSF) (1,2). ISF is likely transmitted 
by the dog tick Rhipicephalus san-
guineus (3). This tick, which is also the 
vector of R. conorii subsp. conorii, has 
low afﬁ  nity for hosts other than dogs. 
Therefore, like MSF, cases of ISF will 
likely be sporadic (4,5). ISF was ﬁ  rst 
reported in Israel (1) and was also re-
cently described in Portugal and Italy 
(6–8). The clinical manifestations of 
ISF are similar to those of other spot-
ted fever group infections, but an in-
oculation eschar is rarely observed and 
a history of tick exposure is not always 
present (4–6,9). The incubation period 
is ≈7–8 days after the tick bite (4).
We describe a 63-year-old man 
who had fatal ISF despite adequate 
therapy. The patient, who lived in 
Switzerland, took a cruise on the 
Mediterranean Sea, sailing for a week 
along the coasts of Crete, Libya, and 
Malta (Figure). With his wife, he visit-
ed several archeological sites in Libya 
(Cyrene, Apollonia, Ptolemais, Leptis 
Magna, Sabratha). Three days after 
returning to Switzerland, the patient 
reported loss of appetite, epigastric 
pain, and loose stools. Four days later, 
a fever (40°C) and generalized rash de-
veloped. The patient was hospitalized 
6 days after symptom onset. At that 
time, he had fever (38.3°C), hypoten-
sion (85/55 mm Hg), tachycardia (100/
min); a maculopapular rash involving 
the trunk, limbs, palms, and soles; and 
petechial lesions on the right arm. The 
patient was confused and exhibited bi-
lateral dysdiadochokinesis. Laboratory 
investigations yielded the following 
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results: C-reactive protein level 183 
mg/L; leukocyte count 4.9 ×109/L; 
platelet count 23 ×109/L; creatinine 741 
μmol/L; sodium 127 mmol/L; aspar-
tate aminotransferase 299 U/L; alanine 
aminotransferase 156 U/L; γ-glutamyl 
transpeptidase 160 U/L; pH 7.45; and 
lactate 4.5 mmol/L. A rapid blood test 
for malaria (OptiMAL-IT, DiaMed, 
Cressier, Switzerland) had negative re-
sults, and peripheral blood smears did 
not show any Plasmodium spp. During 
his trip, the patient had not had contact 
with animals and had no history of tick 
bite. His wife was asymptomatic.
The initial differential diagnosis 
mainly included typhoid fever, lep-
tospirosis, malaria, HIV seroconver-
sion, and MSF. Treatment with intra-
venous doxycycline, 100 mg twice a 
day, and ceftriaxone, 2 g every 24 h, 
was immediately started. The patient 
was admitted to the intensive care unit 
because of hypotension and received 
vasopressors. Twenty-four hours lat-
er, renal function deteriorated, and 
the patient was transferred to our uni-
versity hospital in Lausanne, Switzer-
land, for hemodialysis. Antimicrobial 
drug treatment was switched to intra-
venous imipenem, 500 mg 4 times 
a day, and clarithromycin, 500 mg 
twice a day. On day 8 after symptom 
onset, he had pulseless electrical heart 
activity probably caused by metabol-
ic acidosis. He died on day 11 after 
symptom onset.
Blood was sterile but was not cul-
tured for rickettsiae, and stool culture 
showed no pathogens. Using serum 
obtained on day 6, we conducted a 
Rickettsia spp. microimmunoﬂ  uo-
rescence test; results were negative. 
However, results of a skin biopsy, con-
ducted after 2 days of antibiotherapy, 
were positive by 2 PCRs targeting the 
ompA and gltA genes (10). Sequencing 
allowed postmortem identiﬁ  cation of 
the etiologic agent as R. conorii subsp. 
israelensis. The sequences of ompA 
exhibited 99.8% (532/533 bp) similar-
ity with R. conorii subsp. israelensis 
strain ISTT-CDC1T (GenBank acces-
sion no. U43797), 98.3% (524/533 
bp) with R. conorii subsp. caspia 
strain A-167T (U43791) and 96.8% 
(540/558 bp) with R. conorii subsp. 
conorii strain MalishT (AE008674). 
The sequences of gltA exhibited 
100% (177/177 bp) similarity with R. 
conorii subsp. israelensis (U59727), 
99.4% (176/177 bp) with R. conorii 
subsp.  caspia (U59728), and 98.3% 
(174/177 bp) with R. conorii subsp. 
conorii (AE008677).
Autopsy showed severe pulmo-
nary edema and liver ischemia. The 
brain had petechial hemorrhages in the 
left cerebellum and right frontal lobe, 
as well as a small recent ischemic in-
farction in the right caudate nucleus.
In this case of ISF, delayed medical 
consultation and thus late initiation of 
antimicrobial drug therapy (6 days af-
ter symptoms onset), the patient’s age, 
and his chronic alcohol abuse probably 
contributed to the fatal course. The 
virulence of R. conorii subsp. israel-
ensis might also be higher than that of 
R. conorii subsp. conorii (6,7).
ISF has not been described in any 
of the countries visited by the patient. 
Given the incubation time of spotted 
fever (7–8 days), he was probably in-
fected in Lybia, where he spent days 
6–10 before symptom onset. Geo-
graphic distribution of ISF can thus be 
extended to North Africa. Since ISF 
and MSF share the same vector (Rh. 
sanguineus), disease-endemic areas 
probably overlap.
This report also points out the im-
portance of early empirical treatment. 
Rickettsiosis should be suspected in 
febrile travelers, especially when they 
have a rash, even in the absence of his-
tory of tick exposure and inoculation 
eschar. Counseling before travel to 
areas endemic for spotted fever rick-
ettsioses should include preventive 
measures for tick bites and recommen-
dations to immediately seek medical 
advice in case of fever.
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Figure. Cruise path on the Mediterranean Sea along the coasts of Crete, Libya, and Malta. 
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the manuscript. Written consent for pub-
lication was obtained from the patient’s 
wife.
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Streptococcus suis 
Meningitis without 
History of Animal 
Contact, Italy
To the Editor: Streptococcus suis, 
a major swine pathogen worldwide, is 
emerging as a zoonotic agent capable 
of causing a variety of serious infec-
tions in swine as well as in persons 
exposed to pigs or to pork products. 
These infections include meningitis, 
septicemia, pneumonia, endocarditis, 
arthritis, and septic shock (1,2). De-
spite recent outbreaks among persons 
in China, S. suis disease in humans is 
a rare, probably underdiagnosed in-
fection that usually occurs as sporadic 
cases (1,2). Persons in close occupa-
tional or accidental contact with pigs 
or pork products and those who eat 
uncooked or undercooked pork may 
be at higher risk than others. How-
ever, most infected persons are likely 
healthy carriers, and S. suis is believed 
to induce overt disease (especially 
meningitis) in only some circumstanc-
es (2). We describe a case of S. suis 
meningitis in a 68-year-old man from 
Sardinia, Italy, who had no reported 
contact with swine, other animals, or 
any animal products; the patient also 
had cancer, which was discovered in-
cidentally during the workup.
In November 2007, the patient 
was hospitalized with a 48-hour his-
tory of fever, headache, nausea, and 
general malaise. Physical examina-
tion showed impaired consciousness, 
nuchal rigidity, and a temperature of 
39.5°C. Laboratory ﬁ  ndings  were 
20,700 leukocytes/mm3 with 92% 
neutrophils, glucose 95 mg/dL, and 
C-reactive protein 375 mg/L. Cere-
brospinal ﬂ  uid (CSF) analysis demon-
strated 240 leukocytes/μL with 80% 
polymorphonuclear cells, glucose 
24 mg/dL, and protein 277 mg/dL. 
A computed tomography scan of the 
head showed no abnormal ﬁ  ndings. 
Gram stain of CSF showed gram-pos-
itive cocci, mostly in pairs (Figure).
Empirical therapy consisted of 
intravenous ceftriaxone (2 g twice a 
day) and oral chloramphenicol (2 g 
once a day). On day 5, α-hemolytic 
streptococci were isolated from CSF 
on sheep blood agar and identiﬁ  ed as 
S. suis by using APIStrep (bioMérieux, 
Marcy l’Etoile, France). Serotyping, 
performed by slide agglutination with 
speciﬁ  c antiserum (Statens Serum In-
stitute, Copenhagen, Denmark), iden-
tiﬁ  ed the isolate as serotype 2.
Antimicrobial  drug  –susceptibility 
testing, performed according to guide-
lines of the Clinical and Laboratory 
Standards Institute (www.clsi.org), in-
dicated susceptibility to penicillin, cef-
triaxone, chloramphenicol, levoﬂ  oxa-
cin, and vancomycin and resistance to 
erythromycin (MIC >128 mg/L) and 
tetracycline (MIC 16 mg/L). Erythro-
mycin resistance was constitutive and 
was mediated by the erm(B) determi-
nant; tetracycline resistance was me-
diated by tet(W). Multilocus sequence 
typing (http://ssuis.mlst.net) assigned 
the  S. suis isolate to sequence type 
(ST) 1.
The patient, a retired welder, de-
nied any recent occupational or even 
occasional contact with swine or other 
animals and had no history of eating 
raw or undercooked pork. The pa-
tient’s condition improved; chloram-
phenicol was discontinued on day 10, 
but the 14-day course of ceftriaxone 
was completed. On day 6, the patient 
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